New Calif. Pay-For-Delay Law May Hurt Those It Aims To Help
By Chad Landmon and Chantelle Ankerman ( November 5, 2019, 2:49 PM EST) -- In the continuing effort to reduce the costs of pharmaceuticals, a new California law governing patent settlement agreements was signed into law on Oct. 7. The statute attempts to prevent so-called "pay-for-delay" or "reverse-payment" settlements in which a branded drug company pays a generic pharmaceutical company purportedly to delay the generic coming to market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.